Robert C Mcrae

Title: Innovations by Inventor Robert C. McRae in Pharmaceutical Chemistry

Introduction: Robert C. McRae is a prominent inventor based in Solana Beach, California, renowned for his valuable contributions to pharmaceutical chemistry. With a total of two patents to his name, McRae has developed innovative solutions in the field of cancer treatment, immune disorders, and inflammation.

Latest Patents: McRae's latest patents focus on the crystalline mesylate Form 1 salt of N-hydroxy 2-{6-[(6-fluoro-quinolin-2-ylmethyl)-amino]-3-aza-bicyclo[3.1.0]hex-3-yl}pyrimidine-5-carboxamide. This invention provides methods for producing these solid-state forms, which are significant for preparing pharmaceutical compositions and dosage forms aimed at treating various ailments, particularly cancer and immune-related conditions.

Career Highlights: Robert C. McRae is associated with Viracta Subsidiary, Inc., where he leverages his expertise in developing groundbreaking pharmaceutical solutions. His work epitomizes the innovative spirit needed in today’s competitive biopharmaceutical landscape.

Collaborations: Throughout his career, McRae has collaborated with fellow innovators such as Xiaohu Deng and Wanping Mai. These partnerships have been instrumental in advancing the development of effective therapeutic agents, demonstrating the power of teamwork in scientific research.

Conclusion: Robert C. McRae's contributions to pharmaceutical innovations position him as a significant figure in the industry. His inventions not only address critical health challenges but also showcase the importance of dedicated research and collaboration in advancing medical science. His ongoing work at Viracta Subsidiary, Inc. continues to inspire future developments in treating complex diseases.